Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)

CNY 37.17

(0.38%)

Net Debt Summary of Tibet Rhodiola Pharmaceutical Holding Co.

  • Tibet Rhodiola Pharmaceutical Holding Co.'s latest annual net debt in 2023 was -184.66 Million CNY , up 71.66% from previous year.
  • Tibet Rhodiola Pharmaceutical Holding Co.'s latest quarterly net debt in 2024 Q2 was -376.63 Million CNY , up 73.29% from previous quarter.
  • Tibet Rhodiola Pharmaceutical Holding Co. reported annual net debt of -651.58 Million CNY in 2022, down -188.61% from previous year.
  • Tibet Rhodiola Pharmaceutical Holding Co. reported annual net debt of -225.76 Million CNY in 2021, up 70.22% from previous year.
  • Tibet Rhodiola Pharmaceutical Holding Co. reported quarterly net debt of -1.08 Billion CNY for 2024 Q3, down -189.26% from previous quarter.
  • Tibet Rhodiola Pharmaceutical Holding Co. reported quarterly net debt of -376.63 Million CNY for 2024 Q2, up 73.29% from previous quarter.

Annual Net Debt Chart of Tibet Rhodiola Pharmaceutical Holding Co. (2023 - 1996)

Historical Annual Net Debt of Tibet Rhodiola Pharmaceutical Holding Co. (2023 - 1996)

Year Net Debt Net Debt Growth
2023 -184.66 Million CNY 71.66%
2022 -651.58 Million CNY -188.61%
2021 -225.76 Million CNY 70.22%
2020 -758.1 Million CNY -2.47%
2019 -739.84 Million CNY -39.9%
2018 -528.83 Million CNY -67.67%
2017 -315.4 Million CNY 4.02%
2016 -328.62 Million CNY -19.76%
2015 -274.4 Million CNY -65.84%
2014 -165.46 Million CNY 51.81%
2013 -343.35 Million CNY -232.81%
2012 -103.16 Million CNY -122.08%
2011 -46.45 Million CNY -59.89%
2010 -29.05 Million CNY 55.18%
2009 -64.82 Million CNY -285.69%
2008 34.9 Million CNY 837.97%
2007 3.72 Million CNY -96.69%
2006 112.4 Million CNY -11.44%
2005 126.92 Million CNY -27.48%
2004 175.01 Million CNY -5.39%
2003 184.99 Million CNY -5.15%
2002 195.04 Million CNY 244.63%
2001 56.59 Million CNY 429.69%
2000 -17.16 Million CNY 90.2%
1999 -175.12 Million CNY -504.83%
1998 43.26 Million CNY 48.68%
1997 29.09 Million CNY 450.07%
1996 5.28 Million CNY 0.0%

Peer Net Debt Comparison of Tibet Rhodiola Pharmaceutical Holding Co.

Name Net Debt Net Debt Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. -6.15 Billion CNY 97.0%
Yabao Pharmaceutical Group Co., Ltd -408.64 Million CNY 54.81%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited -5.48 Billion CNY 96.631%
Harbin Pharmaceutical Group Co., Ltd. 498.52 Million CNY 137.042%
Tasly Pharmaceutical Group Co., Ltd -1.49 Billion CNY 87.617%
Zhejiang Medicine Co., Ltd. -658.58 Million CNY 71.96%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited -1.28 Billion CNY 85.633%
Lionco Pharmaceutical Group Co.,Ltd. 222.19 Million CNY 183.11%
Humanwell Healthcare (Group) Co.,Ltd. 5.84 Billion CNY 103.161%
Ginwa Enterprise (Group) Inc. -609.67 Million CNY 69.711%
Joincare Pharmaceutical Group Industry Co.,Ltd. -8.29 Billion CNY 97.773%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. -179.97 Million CNY -2.604%
China Animal Husbandry Industry Co., Ltd. -36.84 Million CNY -401.197%
Jiangsu Jibeier Pharmaceutical Co., Ltd. -684.96 Million CNY 73.04%
Zhejiang Huahai Pharmaceutical Co., Ltd. 6.1 Billion CNY 103.022%
Shanghai Haoyuan Chemexpress Co., Ltd. 598.96 Million CNY 130.831%
Ningbo Menovo Pharmaceutical Co., Ltd. 846.41 Million CNY 121.817%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd -2.47 Billion CNY 92.549%
Chongqing Taiji Industry(Group) Co.,Ltd 2.92 Billion CNY 106.311%
HPGC Renmintongtai Pharmaceutical Corporation 1.01 Billion CNY 118.126%
Nanjing Well Pharmaceutical Group Co.,Ltd. 329.41 Million CNY 156.059%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 276.38 Million CNY 166.814%
Henan Lingrui Pharmaceutical Co., Ltd. -1.34 Billion CNY 86.317%
Shenzhen Chipscreen Biosciences Co., Ltd. 828.33 Million CNY 122.293%
Guizhou Yibai Pharmaceutical Co., Ltd. 379.62 Million CNY 148.644%
Jiangsu Kanion Pharmaceutical Co.,Ltd. -1.92 Billion CNY 90.388%
Zhongzhu Healthcare Holding Co.,Ltd -330.03 Million CNY 44.047%
Beijing Tongrentang Co., Ltd -8.7 Billion CNY 97.879%
KPC Pharmaceuticals, Inc. -321.76 Million CNY 42.608%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. -1.17 Billion CNY 84.332%
North China Pharmaceutical Company Ltd. 10.74 Billion CNY 101.719%
China Resources Double-Crane Pharmaceutical Co.,Ltd. -2.75 Billion CNY 93.293%
Tibet Weixinkang Medicine Co., Ltd. -261.74 Million CNY 29.448%
China National Medicines Corporation Ltd. -7.76 Billion CNY 97.623%
Zhejiang Hisun Pharmaceutical Co., Ltd. 4.1 Billion CNY 104.498%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 1.69 Billion CNY 110.883%
ChengDu ShengNuo Biotec Co.,Ltd. 48.09 Million CNY 483.975%
Dali Pharmaceuticalco.,Ltd 9.46 Million CNY 2050.298%
Changchun BCHT Biotechnology Co. -421.7 Million CNY 56.21%
Zhejiang Shengda Bio-Pharm Co., Ltd. -85.28 Million CNY -116.537%
Shanghai Jiaoda Onlly Co.,Ltd 44.83 Million CNY 511.907%
Jiang Zhong Pharmaceutical Co.,Ltd -1.27 Billion CNY 85.531%
Mayinglong Pharmaceutical Group Co., LTD. -2.6 Billion CNY 92.918%
Cisen Pharmaceutical Co., Ltd. -812.71 Million CNY 77.278%
Hunan Warrant Pharmaceutical Co.,Ltd -355.46 Million CNY 48.05%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 25.97 Billion CNY 100.711%
Jianmin Pharmaceutical Group Co.,Ltd. 196.05 Million CNY 194.191%
Hunan Fangsheng Pharmaceutical Co., Ltd. 470.72 Million CNY 139.23%
Guangxi Wuzhou Zhongheng Group Co.,Ltd -1.17 Billion CNY 84.333%
Guobang Pharma Ltd. -1.13 Billion CNY 83.671%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 495.29 Million CNY 137.284%
Kangmei Pharmaceutical Co., Ltd. -801.59 Million CNY 76.963%
Shandong Buchang Pharmaceuticals Co., Ltd. 2.71 Billion CNY 106.802%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.62 Billion CNY 107.031%
Henan Taloph Pharmaceutical Stock Co.,Ltd 622.63 Million CNY 129.658%
ZhuZhou QianJin Pharmaceutical Co.,Ltd -1.88 Billion CNY 90.184%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 1.41 Billion CNY 113.042%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. -244.27 Million CNY 24.404%
Shanghai Shyndec Pharmaceutical Co., Ltd. -3.47 Billion CNY 94.686%
Shanghai Yizhong Pharmaceutical Co., Ltd. -870.73 Million CNY 78.792%
Sichuan Huiyu Pharmaceutical Co., Ltd. -1.34 Billion CNY 86.29%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 149.69 Million CNY 223.357%
CanSino Biologics Inc. 656.66 Million CNY 128.122%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 424.4 Million CNY 143.512%
Shandong Lukang Pharmaceutical Co.,Ltd. 2.63 Billion CNY 107.004%